<DOC>
	<DOCNO>NCT00304811</DOCNO>
	<brief_summary>The purpose study compare outcome treatment bacteremic MRSA infection vancomycin alone , vancomycin plus gentamicin , vancomycin plus rifampin , vancomycin plus gentamicin rifampin .</brief_summary>
	<brief_title>Vancomycin vs. Vancomycin Plus Gentamycin Treatment MRSA Infection</brief_title>
	<detailed_description>Treatment bacteremic infection ( infection associate positive blood culture ) due Staphylococcus aureus become increasingly problematic result increase prevalence strain resistant beta-lactam antibiotic ( so-called methicillin-resistant Staphylococcus aureus , MRSA ) . About 70 % hospital-related strain S. aureus MRSA , , past 4 year , incidence MRSA community-acquired infection rise 50 % ; data quite representative see elsewhere United States part world . Bacteremic MRSA infection highly problematic least two reason : ( 1 ) serious , substantial morbidity 25 % rate mortality middle-aged adult , principal patient system ; ( 2 ) available antibiotic therapy suboptimal . In pre-MRSA era ( 1982 United States ) , treatment bacteremic S. aureus infection beta-lactam antibiotic nafcillin produce uniform microbiological cure ( Musher DM , McKenzie SO : Infections due Staphylococcus aureus . Medicine 56:383-409 , 1977 ) . This mean , absence untreated focus infection require surgical removal ( myocardial abscess ) , antibiotic rapidly sterilize blood stream . This mean one die ; death complication infection remain common . But , autopsy , generally evidence active infection . Extensive literature examine question whether gentamicin add nafcillin treat kind disease ( review critically DM , Verner EF : Treatment Infections due Staphylococcus aureus . IN The Staphylococci , Ed . J Jeljascewicz , Gustave Fischer Verlag , Stuttgart , New York , pp.407-419 , 1986 ) . Gentamicin produce synergistic bactericidal effect agains S. aureus vitro animal model . In human , addition gentamicin associate rapid sterilization blood stream , prolong gentamicin therapy also associate nephrotoxicity . In contrast , MRSA era , treatment vancomycin associate persistence bacteremia ( positive blood culture ) death active infection . We recently participate prospective observational study document association vancomycin treatment , persistently positive blood culture , persistence active infection treatment S. aureus bacteremia vancomycin ( Chang F-Y , McDonald BB , Peacock , Jr. JE , Musher DM , et al . Staphylococcus aureus bacteremia : recurrence impact antibiotic treatment prospective multicenter study . Medicine 82:333-339 , 2003 ) . There appear close correlation outcome treatment serious S. aureus infection bactericidal activity treat antibiotic vitro use conventional technique ( Musher DM , Verner EF : Treatment infection due Staphylococcus aureus . IN The Staphylococci , Ed . J Jeljascewicz , Gustave Fischer Verlag , Stuttgart , New York , pp.407-419 , 1986 ) . We recently show add low concentration gentamicin vancomycin lead substantial synergistic bactericidal activity MRSA ( Shelburne SA , Musher DM , Hulten K , Ceasar H , Lu MY , Bhaila I , Hamill RJ . In-vitro kill community-associated methicillin-resistant Staphylococcus aureus drug combination . Antimicrob Agents Chemother 48:4016-9 , 2004 ) . Based part analogy nafcillin treat methicillin-susceptible S. aureus infection , part vitro study ( cite ) , physicians regularly add gentamicin vancomycin treat MRSA infection . Others , without even vitro support , add rifampin either instead gentamicin together gentamicin . There clinical study support refute clinically motivated usage . Thus , present , one-third patient MRSA bacteremia VAMC treat vacomycin plus gentamicin , two-thirds receive vancomycin alone ; group receive rifampin . The decisionto add gentamicin make haphazard fashion . Our proposal , MRSA identify acceptable regimen stratify patient prospectively vancomycin alone vancomycin plus gentamicin , stratify group without rifampin .</detailed_description>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<criteria>Patients MRSA blood culture process standard care VAMC Patients next kin willing sign consent randomize social security number one treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>MRSA</keyword>
	<keyword>Methicillin Resistant Staphylococcus aureus</keyword>
</DOC>